Extavia and Weakness - a phase IV clinical study of FDA data
Weakness is found among people who take Extavia, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Extavia and have Weakness. It is created by eHealthMe based on reports of 4,837 people who have side effects when taking Extavia from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,837 people reported to have side effects when taking Extavia.
Among them, 467 people (9.65%) have Weakness.
What is Extavia?
Extavia has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 4,792 Extavia users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,070 drugs and 5,984 conditions by eHealthMe.
Number of Extavia and Weakness reports submitted per year:
Time on Extavia when people have Weakness *:
Gender of people who have Weakness when taking Extavia*:
Age of people who have Weakness when taking Extavia *:
Common drugs people take besides Extavia *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Extavia and have Weakness?Check whether Weakness is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of interferon beta-1b:
- Weakness and drugs with ingredients of interferon beta-1b (2,198 reports)
Alternative drugs to, pros and cons of Extavia:
- Extavia (4,792 reports)
Common Extavia side effects:
Browse all side effects of Extavia:a b c d e f g h i j k l m n o p q r s t u v w x y z
Weakness treatments and more:
- Weakness (474,676 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
Common drugs associated with Weakness:
All the drugs that are associated with Weakness:
- Weakness (5,070 drugs)
Common conditions associated with Weakness:
All the conditions that are associated with Weakness:
- Weakness (5,984 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on interferon beta-1b (the active ingredients of Extavia) and Extavia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tysabri and Gastrointestinal Inflammation - 6 seconds ago
- Escitalopram and Purpura Non-Thrombocytopenic - 8 seconds ago
- Viadur and Bradycardia - 21 seconds ago
- Colchicine and Drug Abuse And Dependence - 25 seconds ago
- Cefotaxime Sodium and Propacet 100 drug interaction - 29 seconds ago
- Zaroxolyn and Fungal Nail Infection - 33 seconds ago
- Reclast and Crying - 40 seconds ago
- Zaroxolyn and Operative Haemorrhage - 44 seconds ago
- Norflex and Tenderness - 50 seconds ago
- Taxol and Arteriopathic Disease - 53 seconds ago